• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2 型糖尿病患者睡眠呼吸暂停综合征的患病率及预测因素。

Prevalence and predictive factors of sleep apnoea syndrome in type 2 diabetic patients.

机构信息

Service de pneumologie, Hôtel-Dieu de Paris, université Paris-Descartes, AP-HP, Paris, France.

出版信息

Diabetes Metab. 2009 Nov;35(5):372-7. doi: 10.1016/j.diabet.2009.03.007. Epub 2009 Aug 15.

DOI:10.1016/j.diabet.2009.03.007
PMID:19683953
Abstract

AIM

This study aimed to assess the prevalence and characteristics of sleep apnoea syndrome (SAS) in patients hospitalized for poorly controlled type 2 diabetes.

METHODS

An overnight ventilatory polygraphic study was systematically performed in 303 consecutive patients.

RESULTS

Overall, 34% of these patients had mild SAS, as defined by a respiratory disturbance index (RDI) of 5-15; 19% had moderate SAS (RDI: 16-29) and 10% had severe SAS (RDI>or=30). The SAS was obstructive in 99% of the apnoeic patients. The percentage of patients with excessive daytime sleepiness (Epworth sleepiness scale>10), fatigue or nocturia did not significantly differ among patients with severe, moderate or mild SAS versus non-apnoeic patients. The percentage of patients who snored was significantly higher in patients with severe or moderate SAS versus non-apnoeic patients. HbA(1c), duration of diabetes and the prevalences of microalbuminuria, retinopathy and peripheral neuropathy did not significantly differ among patients with severe, moderate or mild SAS versus non-apnoeic patients. However, patients with severe or moderate SAS had significantly higher values for body mass index, waist circumference and neck circumference than non-apnoeic patients.

CONCLUSION

In type 2 diabetic patients with poor diabetic control, obstructive SAS is highly prevalent and related to abdominal obesity, and should be systematically screened for, as it cannot be predicted by the clinical data.

摘要

目的

本研究旨在评估因 2 型糖尿病控制不佳而住院的患者中睡眠呼吸暂停综合征(SAS)的患病率和特征。

方法

对 303 例连续患者进行了整夜通气多导睡眠图研究。

结果

这些患者中,34%的患者患有轻度 SAS,定义为呼吸紊乱指数(RDI)为 5-15;19%的患者患有中度 SAS(RDI:16-29),10%的患者患有重度 SAS(RDI>或=30)。SAS 在 99%的呼吸暂停患者中为阻塞性。在日间嗜睡(Epworth 嗜睡量表>10)、疲劳或夜尿症的患者百分比方面,严重、中度或轻度 SAS 患者与非呼吸暂停患者之间没有显著差异。在严重或中度 SAS 患者中,打鼾的患者百分比明显高于非呼吸暂停患者。HbA(1c)、糖尿病病程以及微量白蛋白尿、视网膜病变和周围神经病变的患病率在严重、中度或轻度 SAS 患者与非呼吸暂停患者之间没有显著差异。然而,严重或中度 SAS 患者的体重指数、腰围和颈围明显高于非呼吸暂停患者。

结论

在糖尿病控制不佳的 2 型糖尿病患者中,阻塞性 SAS 非常普遍,与腹部肥胖有关,应系统筛查,因为其不能通过临床数据预测。

相似文献

1
Prevalence and predictive factors of sleep apnoea syndrome in type 2 diabetic patients.2 型糖尿病患者睡眠呼吸暂停综合征的患病率及预测因素。
Diabetes Metab. 2009 Nov;35(5):372-7. doi: 10.1016/j.diabet.2009.03.007. Epub 2009 Aug 15.
2
Disorders of glucose metabolism and insulin resistance in patients with obstructive sleep apnoea syndrome.阻塞性睡眠呼吸暂停综合征患者的糖代谢紊乱和胰岛素抵抗。
Int J Clin Pract. 2012 Jan;66(1):91-7. doi: 10.1111/j.1742-1241.2011.02795.x.
3
At least one in three people with Type 2 diabetes mellitus referred to a diabetes centre has symptomatic obstructive sleep apnoea.在被转诊至糖尿病中心的2型糖尿病患者中,至少每三人就有一人患有症状性阻塞性睡眠呼吸暂停。
Diabet Med. 2014 Nov;31(11):1460-7. doi: 10.1111/dme.12477. Epub 2014 May 20.
4
Differences in abdominal and neck circumferences in patients with and without obstructive sleep apnoea.患有和未患有阻塞性睡眠呼吸暂停的患者腹部和颈部周长的差异。
Eur Respir J. 1992 Apr;5(4):377-81.
5
Relationship between sleep apnoea syndrome, snoring and headaches.睡眠呼吸暂停综合征、打鼾与头痛之间的关系。
Cephalalgia. 2002 Jun;22(5):333-9. doi: 10.1046/j.1468-2982.2002.00303.x.
6
Sleep-related breathing disorders, loud snoring and excessive daytime sleepiness in obese subjects.肥胖受试者的睡眠相关呼吸障碍、大声打鼾和日间过度嗜睡。
Int J Obes Relat Metab Disord. 2001 May;25(5):669-75. doi: 10.1038/sj.ijo.0801603.
7
[Prevalence of sleep apnea in men with metabolic syndrome and controlled hypertension].[代谢综合征合并血压控制良好的男性睡眠呼吸暂停患病率]
Arch Mal Coeur Vaiss. 2007 Aug;100(8):637-41.
8
[Characteristics of sleep apnea syndrome in a cohort of patients with acromegaly].[一组肢端肥大症患者睡眠呼吸暂停综合征的特征]
Rev Mal Respir. 2012 May;29(5):673-9. doi: 10.1016/j.rmr.2011.11.017. Epub 2012 Apr 20.
9
High prevalence of sleep apnea syndrome in patients with long-term pacing: the European Multicenter Polysomnographic Study.长期起搏患者睡眠呼吸暂停综合征的高患病率:欧洲多中心多导睡眠图研究
Circulation. 2007 Apr 3;115(13):1703-9. doi: 10.1161/CIRCULATIONAHA.106.659706. Epub 2007 Mar 12.
10
The role of oxygen saturation measurement and body mass index in distinguishing between non-apnoeic snorers and patients with obstructive sleep apnoea syndrome.血氧饱和度测量和体重指数在区分非呼吸暂停性打鼾者与阻塞性睡眠呼吸暂停低通气综合征患者中的作用。
Clin Otolaryngol Allied Sci. 2002 Oct;27(5):344-6. doi: 10.1046/j.1365-2273.2002.00592.x.

引用本文的文献

1
The association between obstructive sleep apnoea and diabetic peripheral neuropathy in subjects with type 2 diabetes.2型糖尿病患者中阻塞性睡眠呼吸暂停与糖尿病周围神经病变之间的关联。
Front Endocrinol (Lausanne). 2025 Aug 29;16:1643826. doi: 10.3389/fendo.2025.1643826. eCollection 2025.
2
Multidimensional sleep health and diabetic retinopathy: Systematic review and meta-analysis.多维睡眠健康与糖尿病视网膜病变:系统评价和荟萃分析。
Sleep Med Rev. 2024 Apr;74:101891. doi: 10.1016/j.smrv.2023.101891. Epub 2023 Dec 12.
3
The Case for Early Use of Glucagon-like Peptide-1 Receptor Agonists in Obstructive Sleep Apnea Patients with Comorbid Diabetes and Metabolic Syndrome.
胰高血糖素样肽-1受体激动剂在合并糖尿病和代谢综合征的阻塞性睡眠呼吸暂停患者中早期使用的理由。
Life (Basel). 2022 Aug 12;12(8):1222. doi: 10.3390/life12081222.
4
Obstructive sleep apnea is not associated with diabetic retinopathy in diabetes: a prospective case-control study.阻塞性睡眠呼吸暂停与糖尿病患者的糖尿病视网膜病变无关:一项前瞻性病例对照研究。
Sleep Breath. 2023 Mar;27(1):121-128. doi: 10.1007/s11325-022-02578-2. Epub 2022 Feb 9.
5
Obstructive Sleep Apnoea, Other Sleep Parameters and Diabetic Retinopathy.阻塞性睡眠呼吸暂停、其他睡眠参数与糖尿病视网膜病变。
Curr Diab Rep. 2021 Dec 13;21(12):58. doi: 10.1007/s11892-021-01425-0.
6
Screening for obstructive sleep apnea in a diabetic retinopathy clinic in a tertiary care center.在一家三级护理中心的糖尿病视网膜病变诊所筛查阻塞性睡眠呼吸暂停。
Indian J Ophthalmol. 2021 Nov;69(11):3349-3357. doi: 10.4103/ijo.IJO_3633_20.
7
Ocular Complications of Obstructive Sleep Apnea.阻塞性睡眠呼吸暂停的眼部并发症
J Clin Med. 2021 Jul 31;10(15):3422. doi: 10.3390/jcm10153422.
8
Lysine demethylase KDM6B regulates HIF-1α-mediated systemic and cellular responses to intermittent hypoxia.赖氨酸去甲基酶 KDM6B 调节低氧诱导因子-1α 介导的间歇性低氧的全身和细胞反应。
Physiol Genomics. 2021 Sep 1;53(9):385-394. doi: 10.1152/physiolgenomics.00045.2021. Epub 2021 Jul 23.
9
Sleep apnea and eye diseases: evidence of association and potential pathogenic mechanisms.睡眠呼吸暂停与眼部疾病:关联证据及潜在致病机制
J Clin Sleep Med. 2022 Jan 1;18(1):265-278. doi: 10.5664/jcsm.9552.
10
Possible Preventative/Rehabilitative Role of Gliflozins in OSA and T2DM. A Systematic Literature Review-Based Hypothesis.格列净类药物在 OSA 和 T2DM 中的可能预防/康复作用。基于系统文献回顾的假说。
Adv Ther. 2021 Aug;38(8):4195-4214. doi: 10.1007/s12325-021-01791-x. Epub 2021 Jul 17.